ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
MRT
Marti Technologies, Inc.
There isn't enough reported data to score MRT yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MRT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MRT's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MRT PE Valuation
MRT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 154x next year's earnings.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MRT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MRT to return to profit, with revenue growing.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
MRT has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus MRT down 130%.
MRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.01 | — |
| Q3 2026 | -$0.37 | +$0.47 |
| Q4 2025 | -$0.52 | +$0.76 |
| Q3 2025 | -$0.84 | +$0.15 |
| Q2 2025 | -$1.16 | -$0.72 |
| Q1 2025 | -$1.22 | -$0.78 |
| Q4 2024 | -$1.28 | -$0.84 |
| Q3 2024 | -$0.99 | -$0.55 |
| Q2 2024 | -$0.44 | +$0.14 |
MRT is still losing money, but far less than before: $0.37 per share over the past year, against $1.28 at its worst in late 2024.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
MRT has the stronger quarterly revenue trend. Revenue is up 187% for ASTS versus up 740% for MRT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $60.1M | +383% |
| Q4 2025 | $12.5M | +143% |
| Q3 2025 | $12.5M | +143% |
| Q2 2025 | $7.2M | +70% |
| Q1 2025 | $7.2M | +70% |
| Q4 2024 | $5.1M | -50% |
| Q3 2024 | $5.1M | +1982% |
| Q2 2024 | $4.2M | -11% |
MRT's revenue has grown year over year for five quarters in a row: $60M last quarter, up 740% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.8% | +86 points |
| Q4 2025 | -64% | +395 points |
| Q3 2025 | -64% | +395 points |
| Q2 2025 | -88% | +129 points |
| Q1 2025 | -88% | +129 points |
| Q4 2024 | -459% | -224 points |
| Q3 2024 | -459% | -3597 points |
| Q2 2024 | -217% | -68 points |
MRT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
MRT has the stronger cash trend. Its trailing FCF is up 11% versus its history, compared with ASTS at down 363%.
MRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.8M | +$3.2M |
| Q4 2025 | -$5M | +$2.4M |
| Q3 2025 | -$5M | +$2.4M |
| Q2 2025 | -$2.6M | +$2.6M |
| Q1 2025 | -$2.6M | +$2.6M |
| Q4 2024 | -$7.4M | +$5.8M |
| Q3 2024 | -$7.4M | -$2.6M |
| Q2 2024 | -$5.3M | -$275.7K |
MRT has burned cash in almost every quarter: −$14M over the past year, against −$23M the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over MRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
MRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.9% | +4M shares |
| 1 year | +16% | +12.2M shares |
| 3 years | +149% | +51.6M shares |
MRT has 86M diluted shares, up 16% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $86,097 |
| Q3 2025 | $86,097 |
| Q2 2025 | $97,719 |
| Q1 2025 | $97,719 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MRT Net Leverage
MRT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 57.6 | Neutral |
MRT's weekly RSI is 52 (neutral) and its Stochastic is 58 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MRT PE vs Technology Sector
MRT has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
MRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.99 | 1.5% above |
| 20 week MA | $1.91 | 5.8% above |
| 50 week MA | $2.00 | 1% above |
| 100 week MA | $2.43 | 17% below |
| 200 week MA | $3.05 | 34% below |
MRT has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
MRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.75 | $9.89 | +1.4% |
| 2022 | $9.89 | $10.2 | +3.1% |
| 2023 | $10.2 | $0.65 | -94% |
| 2024 | $0.65 | $3.39 | +422% |
| 2025 | $3.39 | $2.31 | -32% |
| 2026 YTD | $2.31 | $2.02 | -13% |
MRT has the edge over ASTS on returns for 2026, with the stronger performance.